Tcg Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 75.00 Cr
- Paid Up Capital ₹ 64.88 Cr
- Company Age 26 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 349.02 Cr
- Satisfied Charges ₹ 1,244.96 Cr
- Revenue Growth 17.04%
- Profit Growth -24.24%
- Ebitda -8.24%
- Net Worth 10.05%
- Total Assets 19.19%
About Tcg Lifesciences
Tcg Lifesciences Private Limited (TLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 August 1998 and has a history of 26 years and six months. Its registered office is in 24 Parganas, West Bengal, India.
The Corporate was formerly known as Chembiotek Research International Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 75.00 Cr and a paid-up capital of Rs 64.88 Cr.
The company currently has active open charges totaling ₹349.02 Cr. The company has closed loans amounting to ₹1,244.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Tcg Lifesciences Private Limited India are Kailash Jaiswal as Company Secretary, Rakesh Poddar as Cfo, and Rakesh Poddar as Cfo. Pratap Chatterjee, Purnendu Chatterjee, Swapan Bhattacharya, and One other member serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73200WB1998PTC087651
- Company No.
087651
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
What products or services does Tcg Lifesciences Private Limited offer?
Tcg Lifesciences Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Content Writing Service, Research Development Services, Product Development Research, Custom Synthesis Service, Weighing Scales & Measuring Tapes, Precision Balance, Medical Treatment Services, Life Science Service.
Who are the key members and board of directors at Tcg Lifesciences?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swapan Bhattacharya  | Managing Director | 03-Aug-1998 | Current |
| Kailash Jaiswal | Company Secretary | 14-Nov-2008 | Current |
| Rakesh Poddar | CFO | 05-Sep-2022 | Current |
| Rakesh Poddar | CFO | 05-Sep-2022 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pratap Chatterjee | Director | 31-Jul-2017 | Current |
Purnendu Chatterjee  | Director | 03-Aug-1998 | Current |
| Goutam Das | Director | 23-Mar-2022 | Current |
Financial Performance of Tcg Lifesciences.
Tcg Lifesciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 17.04% increase. The company also saw a substantial fall in profitability, with a 24.24% decrease in profit. The company's net worth Soared by an impressive increase of 10.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tcg Lifesciences?
In 2022, Tcg Lifesciences had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Clininvent Research Private LimitedSwapan Bhattacharya, Goutam Das and 1 more are mutual person
Tcg Digital Solutions Private LimitedPratap Chatterjee is a mutual person
Labvantage Solutions Private LimitedSwapan Bhattacharya is a mutual person
Premas Biotech Private LimitedGoutam Das is a mutual person
Indian School Of BusinessPurnendu Chatterjee is a mutual person
Asia Society India CentrePurnendu Chatterjee is a mutual person
Charges (Loans)
₹349.02 Cr
₹1,244.96 Cr
Charges Breakdown by Lending Institutions
- Others : 192.02 Cr
- Hdfc Bank Limited : 80.00 Cr
- Yes Bank Limited : 41.00 Cr
- Axis Bank Limited : 36.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Aug 2024 | Axis Bank Limited | ₹15.00 Cr | Open |
| 09 Jan 2024 | Others | ₹20.00 Cr | Open |
| 26 Dec 2023 | Others | ₹20.00 Cr | Open |
| 19 May 2022 | Axis Bank Limited | ₹21.00 Cr | Open |
| 18 May 2022 | Hdfc Bank Limited | ₹20.00 Cr | Open |
How Many Employees Work at Tcg Lifesciences?
Tcg Lifesciences has a workforce of 1234 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tcg Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tcg Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
